Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - DoubtfulReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exponent (EXPO) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Exponent (EXPO) over the last 16 years, with Q4 2025 value amounting to $358.6 million.

  • Exponent's Total Liabilities rose 742.89% to $358.6 million in Q4 2025 from the same period last year, while for Oct 2025 it was $358.6 million, marking a year-over-year increase of 742.89%. This contributed to the annual value of $356.2 million for FY2025, which is 2253.59% up from last year.
  • Per Exponent's latest filing, its Total Liabilities stood at $358.6 million for Q4 2025, which was up 742.89% from $331.7 million recorded in Q3 2025.
  • Exponent's 5-year Total Liabilities high stood at $358.6 million for Q4 2025, and its period low was $199.4 million during Q2 2021.
  • For the 5-year period, Exponent's Total Liabilities averaged around $269.9 million, with its median value being $252.0 million (2023).
  • As far as peak fluctuations go, Exponent's Total Liabilities plummeted by 277.64% in 2023, and later soared by 3414.58% in 2024.
  • Exponent's Total Liabilities (Quarter) stood at $266.7 million in 2021, then fell by 0.29% to $265.9 million in 2022, then increased by 9.32% to $290.7 million in 2023, then grew by 14.83% to $333.8 million in 2024, then grew by 7.43% to $358.6 million in 2025.
  • Its last three reported values are $358.6 million in Q4 2025, $331.7 million for Q3 2025, and $321.8 million during Q2 2025.